Charles River Laboratories International (CRL) Short term Debt (2009 - 2022)

Charles River Laboratories International has reported Short term Debt for 14 years, with the latest figure at $2.1 million in Q3 2022.

• On a quarterly basis, Short term Debt fell 8.62% year-over-year to $2.1 million in Q3 2022; TTM through Sep 2022 was $2.1 million, a 8.62% decrease from a year earlier, with the FY2021 full-year figure at $2.8 million, down 94.43% from the prior year.
• Short term Debt was $2.1 million for Q3 2022 at Charles River Laboratories International, down from $2.4 million in the prior quarter.
• The five-year high for Short term Debt was $53.7 million in Q2 2020, with the low at $2.1 million in Q3 2022.
• Average Short term Debt over 5 years is $22.4 million, with a median of $31.0 million recorded in 2018.
• The sharpest annual moves came in 2019 and 2021: Short term Debt surged 877.21% in 2019, then tumbled 94.43% in 2021.
• Over 5 years, Short term Debt stood at $31.4 million in 2018, then gained by 22.69% to $38.5 million in 2019, then soared by 30.27% to $50.2 million in 2020, then sank by 94.43% to $2.8 million in 2021, then decreased by 25.62% to $2.1 million in 2022.
• The last three Short term Debt figures came in at $2.1 million (Q3 2022), $2.4 million (Q2 2022), and $2.6 million (Q1 2022), per Business Quant data.